Mortgage Blog Raleigh pharma sees stock tumble after stopping trial. Now what? firststargroup June 22, 2022 A Raleigh drug developer's stock dropped hard after the company said it would end a late-stage study for its co-lead drug candidate.
A Raleigh drug developer's stock dropped hard after the company said it would end a late-stage study for its co-lead drug candidate.
